Investors
Presentations & Reports 2021
For investor-related information please contact Gabriella Hold at Automic Group
Ph: +61 411 364 382 E: gabriella.hold@automicgroup.com.au
https://zeliratx.com/presentations/Proactiveinvestors_AU_-_Zelira_Therapeutics_commercialisation_program_to_see_launch_of_suite_of_new_cannabinoid-based_prod.pdf
Zelira Therapeutics’ commercialisation program
Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive
September 1, 2021
https://www.youtube.com/watch?v=muhK--qz0hY
Channel 9 News Perth
Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain
August 25, 2021
https://zeliratx.com/presentations/Zelira_Therapeutics-Cantor_Presentation-June_29_2021.pdf
Presentation at Cantor Fitzgerald International Cannabis Forum
Zelira Therapeutics Investor Slide Deck
June 29, 2021
https://zeliratx.com/presentations/GMT20210629-180208_Video.mp4
Zelira Chairman, Osagie Imasogie and CEO Oludare Odumosu
Zelira Chairman Presentation at Cantor Fitzgerald International Cannabis Forum
June 28, 2021
https://www.youtube.com/watch?v=tLIA9sMAR8c
Zelira Therapeutics and Levin Health
Talking about the upcoming chronic pain clinical trial
June 7, 2021
https://www.youtube.com/watch?v=GreL9lEnjlQ
Zelira Therapeutics well positioned
Zelira Therapeutics are well positioned for ‘multiple product launches in 2021’
April 20, 2021
https://www.youtube.com/watch?v=HRYozkMKtts
Proactive – Zelira Therapeutics sees ‘multiple shots on goal’ with a number of revenue streams
February 25, 2021